Ipamorelin Hilma Biocare 10 mg

Ipamorelin by Hilma Biocare is a selective ghrelin / growth hormone secretagogue receptor agonist that stimulates the body's own growth hormone release. A pentapeptide derived from GHRP-1, it is prized for its high selectivity and mild profile: unlike GHRP-2 and GHRP-6, it does not significantly raise prolactin, cortisol, LH, FSH, TSH or ACTH. That clean, targeted action makes it one of the most popular GH peptides for recovery, physique work and anti-aging, supplied as 10 mg of lyophilized powder per vial.
| Active substance | Ipamorelin (pentapeptide) |
| Manufacturer | Hilma Biocare |
| Strength | 10 mg per vial |
| Form | Lyophilized powder for reconstitution |
| Typical dosage | 200–300 mcg, 1–3× daily |
| Class | Selective GH secretagogue |
Effects and benefits
Ipamorelin produces a stable pulse of growth hormone that supports lean muscle, fat loss and recovery without the appetite spike or hormonal noise of stronger GHRPs. Its clean side-effect profile makes it suitable for longer, lower-key protocols.
- Stimulates natural GH release
- Supports lean muscle and body composition
- Promotes fat loss (lipolysis)
- Minimal effect on prolactin and cortisol
Usage and administration
Ipamorelin is reconstituted with bacteriostatic water and dosed around 200–300 mcg one to three times daily, typically on an empty stomach around training and before sleep. As a research peptide it belongs alongside the rest of the peptides range rather than in an anabolic cycle.
Stacking and combinations
Ipamorelin is most often paired with a GHRH such as CJC-1295 DAC for a stronger, sustained GH release, and is a cleaner alternative to GHRP-2 for those sensitive to appetite or prolactin effects.
Why choose Hilma Biocare
Each vial is produced to consistent pharmaceutical standards with reliable peptide content you can trust. Explore the full Hilma Biocare catalogue to build a complete GH-support stack.
| Characteristics | |
| Shelf Life | 36 months from manufacture date |
| Drug Class | Growth Hormone Secretagogue |
| Concentration | 10 mg per vial |
| Half-Life | Approximately 2 hours |
| Detection Time | Not typically tested in standard drug screenings |
| Active Substance | Ipamorelin |
| Dosage | 200-300 mcg 2-3 times daily |
| Drug Category | Peptide |
| Form | Lyophilized powder |
| Product Packaging | 10 mg vial |
| Liver Toxicity | None |
| Chemical Structure | Synthetic pentapeptide |
